Latest News
Here you can find all the latest news from the MRC CTU at UCL.
Our Capacity Strengthening Hub launches on The Global Health Network today!
Our Capacity Strengthening Hub launches on The Global Health Network today!
Scotland approves the use of abiraterone in patients with high-risk non-metastatic prostate cancer
Scotland approves the use of abiraterone in patients with high-risk non-metastatic prostate cancer
New podcast episode: Sharing results of clinical trials with participants (part 2)
New podcast episode: Sharing results of clinical trials with participants (part 2)
STREAM stage 2 study finds all-oral and six-month treatment regimens to be safe and effective
STREAM stage 2 study finds all-oral and six-month treatment regimens to be safe and effective
Practical guidance for running late-phase platform trials
Practical guidance for running late-phase platform trials